Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 14 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. Cancer statistics for Hispanic/Latino people, 2026.
    Anatu H Saka, Tyler B Kratzer, Angela N Giaquinto +6
    CA: a cancer journal for cliniciansPeer-reviewedCC BY-NC-NDFull text1 citedOncologyEurope PMC
  2. Human papillomavirus infection and risk of cardiovascular disease: A population-based matched cohort study with sibling analysis
    Yunyang Deng, Mark Clements, Chaonan Shen +3
    PLOS MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineInfectious diseaseOncologyPLOS
  3. Brown and white adipocyte like cells derived exosomes differentially regulate stemness, hormone secretion, apoptosis, and lipid metabolism in model cells
    Zeinab Ghesmati, Mohsen Rashid, Shabnam Fayezi +2
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  4. No Overall Survival Benefit with Adding Chemotherapy to Immunotherapy in PD-L1 TPS >= 50% NSCLC: An Agent-Stratified Reassessment
    F. Han, J. Wang, S. Shi +2
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  5. Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma
    L. Camacho, C. Cacho-Navas, J. Agüero +11
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  6. Research Study Attrition and Participant-Informed Retention Strategies Among Cancer Survivors
    Antonio Di Meglio, Camila Kelly Chiodi, Julie Havas +26
    JAMA Network OpenPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  7. Multifaceted Food Effects on Intestinal Drug Uptake Transporters: Mechanistic Insights from Small Molecules to Macromolecules
    Ikumi Tamai
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOncologyJ-STAGE
  8. Successful Treatment of Synchronous Double Lung and Colon Cancers Using Immune Checkpoint Inhibitors
    Shuichi Matsuoka, Hirokazu Tokuyasu, Katsunori Arai +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  9. Integrating AI, RNA Vaccines, and CAR‐T Cells for Personalized Treatment
    Diala Haykal, Brigitte Dréno
    Journal of Immunology ResearchPeer-reviewedCC BY 4.0Full textOncologyHAL
  10. Engineering Soluble Recombinant BCMA for Ide‐Cel Labeling
    Ly Phuong Vy Nguyen, Christelle Oblet, Alice Barbarin +11
    European Journal of ImmunologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  11. Paclitaxel-induced neuroinflammation after systemic administration in male and female mice
    Martial Caillaud, Yogesh Rakholia, Lauren Soleo +6
    The Journal of PainPeer-reviewedLicence not stated4 citedOncologyHAL
  12. Transient pancreatic enlargement with peripancreatic inflammatory changes two days before clinical presentation and diagnosis of atezolizumab-related fulminant type 1 diabetes mellitus followed by pancreatic atrophy: a case report with review of literature
    Takahiko Inukai, Takahiro Tsutsumi, Miku Yamazaki +4
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  13. Clinical outcomes of hepatitis B virus-related versus non-B non-C hepatocellular carcinoma treated with transarterial chemoembolization, tyrosine kinase inhibitors, and PD-1 inhibitors: a retrospective cohort study.
    Shi-Tao Lu, Ya-Pan Guo, Yang Liu +3
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  14. FAM84B drives colon adenocarcinoma progression via stemness maintenance and tumor microenvironment remodeling.
    Qinghua Li, Zichao Cao, Xiangyue Guo +7
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  15. Outcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.
    Rajiv Shah, Martin Reck, Christian Grohé +19
    JTO clinical and research reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  16. In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges
    Ziyi Zhang, Xingxing Shang, Tong Zhang +1
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  17. Improving computational tumor ploidy estimation in complex cancer genomes through flow-cytometry-guided calibration
    Thomas Butters, Dahmane Oukrif, Punn Tannirandorn +18
    Cell Reports MethodsPeer-reviewedCC BY 4.0Full textOncologyPMC
  18. Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
    Ryan T. Hughes, Paul J. Black, India R. Wood +10
    JTO clinical and research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  19. Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
    Ryan T. Hughes, MD, Paul J. Black, PhD, India R. Wood, MS +10
    JTO Clinical and Research ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyDOAJPMC
  20. Brief Report: Combination Capmatinib and Trametinib in Metastatic MET-Driven NSCLC.
    Tyiesha Brown, Matthew S Lara, Fei Jiang +4
    JTO clinical and research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  21. Ex vivo glioblastoma migration phenotypes define clinical recurrence and tumor heterogeneity
    J. Hou, M. McMahon, A. Ni +11
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. A Microneurosurgical Survival Platform for Elucidating Mechanisms of Brain Tumor Recurrence and Metastasis
    D. Das, B. Nakamura, J. Neman
    bioRxivPreprintPublic domainFull textOncologybioRxiv
  23. VITAL-3D: Volumetric Single-Cell Quantification Reveals Microenvironment-Dependent Drug Responses in Breast Cancer
    P.-H. Wu, C. Jin, T. Chu +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  24. Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR
    Jiaqian Liu, Na Bo, Patrick Nana-Sinkam +1
    JTO clinical and research reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  25. LINC00536 regulates transcriptional repressor TRPS1 in breast cancer
    R. Zhang, J. Li, D. Badescu +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv